课题基金 / 基金详情

Regulation of oncogenes or tumor suppressor genes in Urological cancer by micro RNA

Regulation of oncogenes or tumor suppressor genes in Urological cancer by micro RNA
Micro RNA对泌尿系癌症中癌基因或抑癌基因的调控
批准号:
22591759
负责人:
TOMITA Yoshihiko
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

TOMITA Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
miR-199a和miR-101在肾细胞癌(RCC)中表达被抑制,其强制表达导致GSK3β和EZH2的抑制,从而降低癌细胞的增殖。重新引入miR-199a和/或miR-101可能是一种有益的治疗策略。ATBF1的表达降低与RCC的恶性倾向相关。hsa-miR-203, hsa-miR-194, hsa-miR-204被认为是ATBF1的抑制因子,可能是另一种新的治疗方式的新靶点。
英文摘要
Enforced expressions of miR-199a and miR-101, of which expressions are inhibited in renal cell cancer (RCC), leads to suppression of GSK3β and EZH2 resulting in reducing cancer cell proliferation. Re-introduction of miR-199a and/or miR-101 might be a beneficial treatment strategy. Reduced expression of ATBF1 is correlated with more malignant character of RCC. hsa-miR-203, hsa-miR-194, hsa-miR-204 are proposed as suppressors of ATBF1 might be novel targets for another new treatment modality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yoshihiko Tomita Low miR-199a expression in Renal Cell Carcinoma (RCC) is related to malignant phenotype via upregulation of GSK-3 β
Yoshihiko Tomita 肾细胞癌 (RCC) 中 miR-199a 的低表达通过 GSK-3 β 的上调与恶性表型相关
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Masaaki Tsukigi, Vladimir Bilim, Kaori Yuuki, Andrey Ugolkov, Sei Naito,Hisashi Kawazoe, Toshihiko Sakurai, Noriaki Hoshoya, Narisawa Takahumi, Akira Nagaoka, Tomoyuki Kato, Mototsugu Oya, Teiichi Motoyama]
通讯作者: Teiichi Motoyama
腎細胞癌におけるmiR-199aの低発現は、GSK3βを上昇させ、癌増殖に働く
肾细胞癌中 miR-199a 的低表达会增加 GSK3β 并在癌症生长中发挥作用。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [柴田康博, 新井誠二, 小池秀和, 松井博, 野村昌史, 伊藤一人, 本間誠次郎, 鈴木和浩, 柴田康博, 柴田康博, 柴田康博, 柴田康博, 槻木真明]
通讯作者: 槻木真明
Improvement of Treatment for Urological Cancer by controlling Function of Apotosis-associated molecules using siRNA.
  • 批准号:
    17390435
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $4.68万
  • 财政年份:
    2005
  • 负责人:
    TOMITA Yoshihiko
  • 依托单位:
Possibility of new treatment modality by inhibition of anti-apoptotic molecule XIAP
  • 批准号:
    14370506
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.0万
  • 财政年份:
    2002
  • 负责人:
    TOMITA Yoshihiko
  • 依托单位:
Significance of newly identified apoptosis-related p19^<ARF> gene alteration in Urological tumors.
  • 批准号:
    12470329
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $1.73万
  • 财政年份:
    2000
  • 负责人:
    TOMITA Yoshihiko
  • 依托单位:
APPLICATION OF BGL-2 ANTISENSE OLIGO-DNA FOR GENE THERAPY TO UROLOGICAL CANCER.
  • 批准号:
    10470333
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.85万
  • 财政年份:
    1998
  • 负责人:
    TOMITA Yoshihiko
  • 依托单位:
海外基金